ERBB2 and breast carcinoma: We initially tested the effect of 2 widely used statins on the viability of a panel of 15 breast cancer cell lines, representative of the major breast cancer molecular subtypes; luminal (4 cell lines), HER2 (2 cell lines) and TNBC (9 cell lines).